Huntington's disease, behavioral disturbances, and kynurenines: preclinical findings and therapeutic perspectives.
Vécsei
L
L
Department of Neurology, Szent-Györgyi University Medical School, Szeged, Hungary.
Beal
M F
MF
D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy / Q000503:physiopathology*; D007737:Kynurenine / Q000502:physiology*; D010215:Papio; D011339:Probenecid / Q000627:therapeutic use; D051381:Rats; D017470:Receptors, Glutamate / Q000187:drug effects / Q000502:physiology; D012920:Social Behavior Disorders / Q000188:drug therapy / Q000503:physiopathology*
D017470:Receptors, Glutamate; D007737:Kynurenine; D011339:Probenecid